Contact Eric KH

Speaking Engagements

  

Oligonucleotide Therapeutics - the emerging medicine class - are harnessing the therapeutic benefit of targeting genetic material utilising oligonucleotide conjugates, antisense oligonucleotides (ASOs), mRNA and RNAi.

21-22 September 2022